{"pmid":32406952,"title":"Hypoalbuminemia predicts the outcome of COVID-19 independent of age and co-morbidity.","text":["Hypoalbuminemia predicts the outcome of COVID-19 independent of age and co-morbidity.","BACKGROUND: The coronavirus disease 2019 (COVID-19) has evolved into a pandemic rapidly. Most of the literature showed that the elevated liver enzymes in COVID-19 are of little clinical significance. Lower albumin level is seen in severe COVID-19 and is not parallel to the changes in ALT and AST levels. We aimed to explore the impact of hypoalbuminemia in COVID-19. METHODS: This retrospective cohort study included adult patients with confirmed COVID-19. The relationship between hypoalbuminemia and death was studied using binary logistic analysis. RESULTS: A total of 299 adult patients were included, 160 (53.5%) were males and the average age was 53.4 +/- 16.7 years. The median time from the onset of illness to admission was 3 days (interquartile ranges 2-5). Approximately one-third of patients had comorbidities. Hypoalbuminemia (<35g/L) was found in 106 (35.5%) patients. The difference in albumin was considerable between survivors and non-survivors (37.6 +/- 6.2 vs. 30.5 +/- 4.0, P < 0.001). Serum albumin level was inversely correlated to white blood cell (r = -0.149, P = 0.01) and neutrophil to lymphocyte ratio (r = -0.298, P <0.001). Multivariate analysis showed the presence of comorbidities (OR = 6.816, 95%CI: 1.361-34.133), lymphopenia (OR = 13.130, 95%CI: 1.632-105.658) and hypoalbuminemia (OR = 6.394, 95%CI: 1.315-31.092) were independent predictive factors for mortality. CONCLUSIONS: Hypoalbuminemia was associated with the outcome of COVID-19. The potential therapeutic value of albumin infusion in COVID-19 should be further explored at the earliest. This article is protected by copyright. All rights reserved.","J Med Virol","Huang, Jiaofeng","Cheng, Aiguo","Kumar, Rahul","Fang, Yingying","Chen, Gongping","Zhu, Yueyong","Lin, Su","32406952"],"abstract":["BACKGROUND: The coronavirus disease 2019 (COVID-19) has evolved into a pandemic rapidly. Most of the literature showed that the elevated liver enzymes in COVID-19 are of little clinical significance. Lower albumin level is seen in severe COVID-19 and is not parallel to the changes in ALT and AST levels. We aimed to explore the impact of hypoalbuminemia in COVID-19. METHODS: This retrospective cohort study included adult patients with confirmed COVID-19. The relationship between hypoalbuminemia and death was studied using binary logistic analysis. RESULTS: A total of 299 adult patients were included, 160 (53.5%) were males and the average age was 53.4 +/- 16.7 years. The median time from the onset of illness to admission was 3 days (interquartile ranges 2-5). Approximately one-third of patients had comorbidities. Hypoalbuminemia (<35g/L) was found in 106 (35.5%) patients. The difference in albumin was considerable between survivors and non-survivors (37.6 +/- 6.2 vs. 30.5 +/- 4.0, P < 0.001). Serum albumin level was inversely correlated to white blood cell (r = -0.149, P = 0.01) and neutrophil to lymphocyte ratio (r = -0.298, P <0.001). Multivariate analysis showed the presence of comorbidities (OR = 6.816, 95%CI: 1.361-34.133), lymphopenia (OR = 13.130, 95%CI: 1.632-105.658) and hypoalbuminemia (OR = 6.394, 95%CI: 1.315-31.092) were independent predictive factors for mortality. CONCLUSIONS: Hypoalbuminemia was associated with the outcome of COVID-19. The potential therapeutic value of albumin infusion in COVID-19 should be further explored at the earliest. This article is protected by copyright. All rights reserved."],"journal":"J Med Virol","authors":["Huang, Jiaofeng","Cheng, Aiguo","Kumar, Rahul","Fang, Yingying","Chen, Gongping","Zhu, Yueyong","Lin, Su"],"date":"2020-05-15T11:00:00Z","year":2020,"_id":"32406952","source":"PubMed","week":"202020|May 11 - May 17","doi":"10.1002/jmv.26003","keywords":["covid-19","hypoalbuminemia","mortality","prediction","risk factor"],"locations":["lymphopenia","Hypoalbuminemia"],"topics":["Treatment","Diagnosis"],"weight":1,"_version_":1666802845532291072,"score":9.490897,"similar":[{"pmid":32488888,"title":"Elevated serum aspartate aminotransferase level identifies patients with coronavirus disease 2019 and predicts the length of hospital stay.","text":["Elevated serum aspartate aminotransferase level identifies patients with coronavirus disease 2019 and predicts the length of hospital stay.","BACKGROUND: Coronavirus disease 2019 (COVID-19) has become a worldwide public health emergency. This study aimed to investigate the clinical significance of liver blood tests in COVID-19 patients. METHODS: The analysis included clinical data of 23 patients with suspected COVID-19 and 66 patients with confirmed COVID-19 from January 25 to February 20, 2020. The relationship between liver blood test results, liver condition (HBsAb positive, HBcAb positive, and fatty liver disease), and duration of hospital stay among COVID-19 patients was analyzed. RESULTS: The median hospital stay of COVID-19 patients was 6 days. Serum albumin (Alb) level was lower in patients with COVID-19 confirmed on admission than in patients with suspected COVID-19 (40.08 g/L vs 42.50 g/L, P = .016), while the level of aspartate aminotransferase (AST) was higher (23 U/L vs 18 U/L, P = .005). Abnormal results of liver blood tests in patients with COVID-19 included increased levels of alanine transaminase (ALT) (21.2%, 14 patients), AST (15.2%, 10 patients), and gamma-glutamyl transpeptidase (GGT) (22.7%, 15 patients). After 5-10 days of treatment, levels of Alb and AST in COVID-19 patients were significantly decreased (P < .001 and P = .027, respectively). Abnormal levels of Alb and AST in patients with COVID-19 were not associated with the liver condition (all P > .05). In addition, only levels of AST were positively correlated with the duration of hospital stay (r = .334, P = .007). CONCLUSION: Abnormal results of the liver blood test were found in COVID-19 patients. The COVID-19 patients on admission with the higher levels of AST might have longer hospital stays.","J Clin Lab Anal","Gu, Xuexiang","Li, Xiangyu","An, Xusheng","Yang, Shufeng","Wu, Shangnong","Yang, Xiaozhong","Wang, Honggang","32488888"],"abstract":["BACKGROUND: Coronavirus disease 2019 (COVID-19) has become a worldwide public health emergency. This study aimed to investigate the clinical significance of liver blood tests in COVID-19 patients. METHODS: The analysis included clinical data of 23 patients with suspected COVID-19 and 66 patients with confirmed COVID-19 from January 25 to February 20, 2020. The relationship between liver blood test results, liver condition (HBsAb positive, HBcAb positive, and fatty liver disease), and duration of hospital stay among COVID-19 patients was analyzed. RESULTS: The median hospital stay of COVID-19 patients was 6 days. Serum albumin (Alb) level was lower in patients with COVID-19 confirmed on admission than in patients with suspected COVID-19 (40.08 g/L vs 42.50 g/L, P = .016), while the level of aspartate aminotransferase (AST) was higher (23 U/L vs 18 U/L, P = .005). Abnormal results of liver blood tests in patients with COVID-19 included increased levels of alanine transaminase (ALT) (21.2%, 14 patients), AST (15.2%, 10 patients), and gamma-glutamyl transpeptidase (GGT) (22.7%, 15 patients). After 5-10 days of treatment, levels of Alb and AST in COVID-19 patients were significantly decreased (P < .001 and P = .027, respectively). Abnormal levels of Alb and AST in patients with COVID-19 were not associated with the liver condition (all P > .05). In addition, only levels of AST were positively correlated with the duration of hospital stay (r = .334, P = .007). CONCLUSION: Abnormal results of the liver blood test were found in COVID-19 patients. The COVID-19 patients on admission with the higher levels of AST might have longer hospital stays."],"journal":"J Clin Lab Anal","authors":["Gu, Xuexiang","Li, Xiangyu","An, Xusheng","Yang, Shufeng","Wu, Shangnong","Yang, Xiaozhong","Wang, Honggang"],"date":"2020-06-04T11:00:00Z","year":2020,"_id":"32488888","source":"PubMed","week":"202023|Jun 01 - Jun 07","doi":"10.1002/jcla.23391","keywords":["covid-19","aspartate aminotransferase","fatty liver disease","hospital stay","liver blood test"],"topics":["Diagnosis","Treatment"],"weight":1,"_version_":1668623433517236224,"score":255.90714},{"pmid":32239796,"title":"Liver impairment in COVID-19 patients: A retrospective analysis of 115 cases from a single centre in Wuhan city, China.","text":["Liver impairment in COVID-19 patients: A retrospective analysis of 115 cases from a single centre in Wuhan city, China.","BACKGROUND: The SARS-CoV-2 pandemic is an ongoing global health emergency. The aim of our study was to investigate the changes of liver function and its clinical significance in COVID-19 patients. METHOD: This retrospective, single-centre study was conducted on 115 confirmed cases of COVID-19 in Zhongnan hospital of Wuhan University from 18 January 2020 to 22 February 2020. Liver function and related indexes were analysed to evaluate its relationship with disease progression in COVID-19 patients. RESULTS: Part of the COVID-19 patients presented with varying degrees of abnormality in liver function indexes. However, the levels of ALT, AST, TBIL, GGT and LDH in COVID-19 patients were not significantly different when compared with hospitalised community-acquired pneumonia patients, and the levels of albumin is even significantly higher. The levels of ALT, AST, TBIL, LDH and INR showed statistically significant elevation in severe COVID-19 cases compared with that in mild cases. However, the clinical significance of the elevation is unremarkable. Majority of severe COVID-19 patients showed significantly decreasing in albumin level and continuously decreasing in the progress of illness. Most of the liver function indexes in COVID-19 patients were correlated with CRP and NLR, the markers of inflammation. Logistic regression analysis further identified NLR as the independent risk factor for severe COVID-19, as well as age. CONCLUSIONS: Although abnormalities of liver function indexes are common in COVID-19 patients, the impairment of liver function is not a prominent feature of COVID-19, and also may not have serious clinical consequences.","Liver Int","Zhang, Yafei","Zheng, Liang","Liu, Lan","Zhao, Mengya","Xiao, Jun","Zhao, Qiu","32239796"],"abstract":["BACKGROUND: The SARS-CoV-2 pandemic is an ongoing global health emergency. The aim of our study was to investigate the changes of liver function and its clinical significance in COVID-19 patients. METHOD: This retrospective, single-centre study was conducted on 115 confirmed cases of COVID-19 in Zhongnan hospital of Wuhan University from 18 January 2020 to 22 February 2020. Liver function and related indexes were analysed to evaluate its relationship with disease progression in COVID-19 patients. RESULTS: Part of the COVID-19 patients presented with varying degrees of abnormality in liver function indexes. However, the levels of ALT, AST, TBIL, GGT and LDH in COVID-19 patients were not significantly different when compared with hospitalised community-acquired pneumonia patients, and the levels of albumin is even significantly higher. The levels of ALT, AST, TBIL, LDH and INR showed statistically significant elevation in severe COVID-19 cases compared with that in mild cases. However, the clinical significance of the elevation is unremarkable. Majority of severe COVID-19 patients showed significantly decreasing in albumin level and continuously decreasing in the progress of illness. Most of the liver function indexes in COVID-19 patients were correlated with CRP and NLR, the markers of inflammation. Logistic regression analysis further identified NLR as the independent risk factor for severe COVID-19, as well as age. CONCLUSIONS: Although abnormalities of liver function indexes are common in COVID-19 patients, the impairment of liver function is not a prominent feature of COVID-19, and also may not have serious clinical consequences."],"journal":"Liver Int","authors":["Zhang, Yafei","Zheng, Liang","Liu, Lan","Zhao, Mengya","Xiao, Jun","Zhao, Qiu"],"date":"2020-04-03T11:00:00Z","year":2020,"_id":"32239796","source":"PubMed","week":"202014|Mar 30 - Apr 05","doi":"10.1111/liv.14455","keywords":["covid-19","sars-cov-2","wuhan","clinical significance","liver function"],"locations":["Zhongnan","Wuhan","China"],"countries":["China"],"countries_codes":["CHN|China"],"topics":["Diagnosis"],"weight":1,"_version_":1666138490342998016,"score":239.1245},{"pmid":32439209,"title":"Characteristics and prognostic factors of disease severity in patients with COVID-19: The Beijing experience.","text":["Characteristics and prognostic factors of disease severity in patients with COVID-19: The Beijing experience.","COVID-19 has become one of the worst infectious disease outbreaks of recent times, with over 2.1 million cases and 120,000 deaths so far. Our study investigated the demographic, clinical, laboratory and imaging features of 63 patients with COVID-19 in Beijing. Patients were classified into four groups, mild, moderate, severe and critically ill. The mean age of our patients was 47 years of age (range 3-85) and there was a slight male predominance (58.7%). Thirty percent of our patients had severe or critically ill disease, but only 20% of severe and 33% of critically ill patients had been to Wuhan. Fever was the most common presentation (84.1%), but cough was present in only slightly over half of the patients. We found that lymphocyte and eosinophils count were significantly decreased in patients with severe disease (p = 0.001 and p = 0.000, respectively). Eosinopenia was a feature of higher levels of severity. Peripheral CD4(+), CD8(+) T lymphocytes, and B lymphocytes were significantly decreased in severe and critically ill patients, but there was only a non-statistically significant downward trend in NK cell numbers with severity. Of note is that liver function tests including AST, ALT, GGT and LDH were elevated, and albumin was decreased. The inflammatory markers CRP, ESR and ferritin were elevated in patients with severe disease or worse. IL-6 levels were also higher, indicating that the presence of a hyperimmune inflammatory state portends higher morbidity and mortality. In a binary logistic regression model, C-reactive protein level (OR 1.073, [CI, 1.013-1.136]; p = 0.017), CD8 T lymphocyte counts (OR 0.989, [CI, 0.979-1.000]; p = 0.043), and D-dimer (OR 5.313, [CI, 0.325-86.816]; p = 0.241) were independent predictors of disease severity.","J Autoimmun","Sun, Ying","Dong, Yanli","Wang, Lifeng","Xie, Huan","Li, Baosen","Chang, Christopher","Wang, Fu-Sheng","32439209"],"abstract":["COVID-19 has become one of the worst infectious disease outbreaks of recent times, with over 2.1 million cases and 120,000 deaths so far. Our study investigated the demographic, clinical, laboratory and imaging features of 63 patients with COVID-19 in Beijing. Patients were classified into four groups, mild, moderate, severe and critically ill. The mean age of our patients was 47 years of age (range 3-85) and there was a slight male predominance (58.7%). Thirty percent of our patients had severe or critically ill disease, but only 20% of severe and 33% of critically ill patients had been to Wuhan. Fever was the most common presentation (84.1%), but cough was present in only slightly over half of the patients. We found that lymphocyte and eosinophils count were significantly decreased in patients with severe disease (p = 0.001 and p = 0.000, respectively). Eosinopenia was a feature of higher levels of severity. Peripheral CD4(+), CD8(+) T lymphocytes, and B lymphocytes were significantly decreased in severe and critically ill patients, but there was only a non-statistically significant downward trend in NK cell numbers with severity. Of note is that liver function tests including AST, ALT, GGT and LDH were elevated, and albumin was decreased. The inflammatory markers CRP, ESR and ferritin were elevated in patients with severe disease or worse. IL-6 levels were also higher, indicating that the presence of a hyperimmune inflammatory state portends higher morbidity and mortality. In a binary logistic regression model, C-reactive protein level (OR 1.073, [CI, 1.013-1.136]; p = 0.017), CD8 T lymphocyte counts (OR 0.989, [CI, 0.979-1.000]; p = 0.043), and D-dimer (OR 5.313, [CI, 0.325-86.816]; p = 0.241) were independent predictors of disease severity."],"journal":"J Autoimmun","authors":["Sun, Ying","Dong, Yanli","Wang, Lifeng","Xie, Huan","Li, Baosen","Chang, Christopher","Wang, Fu-Sheng"],"date":"2020-05-23T11:00:00Z","year":2020,"_id":"32439209","source":"PubMed","week":"202021|May 18 - May 24","doi":"10.1016/j.jaut.2020.102473","keywords":["2019 novel coronavirus disease","covid-19","cytokine storm","elevated liver enzymes","interleukin-6","lymphocyte subsets","mortality","prognosis","sars-cov-2"],"locations":["Beijing","Wuhan","Eosinopenia","Beijing"],"countries":["China"],"countries_codes":["CHN|China"],"topics":["Treatment","Diagnosis"],"weight":1,"_version_":1667523504855056386,"score":229.32327},{"pmid":32153170,"title":"[Clinical characteristics and influencing factors of patients with novel coronavirus pneumonia combined with liver injury in Shaanxi region].","text":["[Clinical characteristics and influencing factors of patients with novel coronavirus pneumonia combined with liver injury in Shaanxi region].","Objective: To understand the clinical characteristics, change of liver function, influencing factors and prognosis in hospitalized patients with coronavirus disease-19 (COVID-19) combined with liver injury. Methods: The general conditions, biochemical indicators of liver, blood clotting mechanism, routine blood test, UGT1A1 * 28 gene polymorphism and other data of 40 cases with COVID-19 admitted to the isolation ward of Tangdu Hospital were retrospectively analyzed. The clinical characteristics, influencing factors and prognosis of liver injury in patients with liver injury group and those with normal liver function group were compared. The mean of two samples in univariate analysis was compared by t-test and analysis of variance. The counting data was measured by chi(2) tests. The non-normal distribution measurement data were described by the median, and the non-parametric test was used. Statistically significant influencing factors were used as the independent variables in univariate analysis. Multiple logistic regression analysis was used to analyze the main influencing factors of liver injury. Results: Of the 40 cases, 25 were male (62.5%) and 15 were female (37.5%), aged 22 to 83 (53.87 +/- 15.84) years. Liver injury was occurred in 22 cases (55%) during the course of the disease. Alanine aminotransferase (ALT) and aspartate aminotransferase (AST) level was initially increased (4.4 to 3.5 times of the normal value) along with decrease of albumin in the second week, and the difference was statistically significant (P < 0.001). Ten cases (43.5%) had highest abnormal total blood bilirubin (54.1 mumol/ L). There was no correlation between the increase in transaminase and the increase in total blood bilirubin (R = -0.006, P = 0.972). Three cases had prothrombin activity (PTA) of </= 50%, 10 cases had elevated FDP, and 13 cases had elevated D-dimer, all of whom were severe or critically ill. Liver function injury was more likely to occur in patients who used many types of drugs and large amounts of hormones (P = 0.002, P = 0.031), and there was no correlation with the TA6TA7 mutation in the UGT1A1 * 28 gene locus. Multiple regression analysis showed that the occurrence of liver injury was only related to critical illness. The liver function of all patients had recovered within one week after conventional liver protection treatment. Conclusion: COVID-19 combined with liver function injury may be due to the slight elevation of transaminase, mostly around the second week of the disease course. Severe patients have a higher proportion of liver injury, and critical type is an independent risk factor for liver injury.","Zhonghua Gan Zang Bing Za Zhi","Yao, N","Wang, S N","Lian, J Q","Sun, Y T","Zhang, G F","Kang, W Z","Kang, W","32153170"],"abstract":["Objective: To understand the clinical characteristics, change of liver function, influencing factors and prognosis in hospitalized patients with coronavirus disease-19 (COVID-19) combined with liver injury. Methods: The general conditions, biochemical indicators of liver, blood clotting mechanism, routine blood test, UGT1A1 * 28 gene polymorphism and other data of 40 cases with COVID-19 admitted to the isolation ward of Tangdu Hospital were retrospectively analyzed. The clinical characteristics, influencing factors and prognosis of liver injury in patients with liver injury group and those with normal liver function group were compared. The mean of two samples in univariate analysis was compared by t-test and analysis of variance. The counting data was measured by chi(2) tests. The non-normal distribution measurement data were described by the median, and the non-parametric test was used. Statistically significant influencing factors were used as the independent variables in univariate analysis. Multiple logistic regression analysis was used to analyze the main influencing factors of liver injury. Results: Of the 40 cases, 25 were male (62.5%) and 15 were female (37.5%), aged 22 to 83 (53.87 +/- 15.84) years. Liver injury was occurred in 22 cases (55%) during the course of the disease. Alanine aminotransferase (ALT) and aspartate aminotransferase (AST) level was initially increased (4.4 to 3.5 times of the normal value) along with decrease of albumin in the second week, and the difference was statistically significant (P < 0.001). Ten cases (43.5%) had highest abnormal total blood bilirubin (54.1 mumol/ L). There was no correlation between the increase in transaminase and the increase in total blood bilirubin (R = -0.006, P = 0.972). Three cases had prothrombin activity (PTA) of </= 50%, 10 cases had elevated FDP, and 13 cases had elevated D-dimer, all of whom were severe or critically ill. Liver function injury was more likely to occur in patients who used many types of drugs and large amounts of hormones (P = 0.002, P = 0.031), and there was no correlation with the TA6TA7 mutation in the UGT1A1 * 28 gene locus. Multiple regression analysis showed that the occurrence of liver injury was only related to critical illness. The liver function of all patients had recovered within one week after conventional liver protection treatment. Conclusion: COVID-19 combined with liver function injury may be due to the slight elevation of transaminase, mostly around the second week of the disease course. Severe patients have a higher proportion of liver injury, and critical type is an independent risk factor for liver injury."],"journal":"Zhonghua Gan Zang Bing Za Zhi","authors":["Yao, N","Wang, S N","Lian, J Q","Sun, Y T","Zhang, G F","Kang, W Z","Kang, W"],"date":"2020-03-11T11:00:00Z","year":2020,"_id":"32153170","source":"PubMed","week":"202011|Mar 09 - Mar 15","doi":"10.3760/cma.j.cn501113-20200226-00070","keywords":["covid-19","clinical characteristics","liver function","liver injury","prognosis","risk factor"],"locations":["Shaanxi"],"countries":["China"],"countries_codes":["CHN|China"],"e_drugs":["Bilirubin"],"topics":["Mechanism","Diagnosis"],"weight":1,"_version_":1666138490668056576,"score":224.05266},{"pmid":32386449,"title":"Liver injury is associated with severe Coronavirus disease 2019 (COVID-19) infection: a systematic review and meta-analysis of retrospective studies.","text":["Liver injury is associated with severe Coronavirus disease 2019 (COVID-19) infection: a systematic review and meta-analysis of retrospective studies.","AIM: The Coronavirus disease 2019 (COVID-19) outbreak is a major threat to human beings. Lung injury has been reported as the major outcome of COVID-19 infection. However, liver damage has also been considered to occur in severe cases. Current meta-analysis of retrospective studies was done to summarize available findings on the association between liver injury and severity of COVID-19 infection. METHODS: Online databases including PubMed, Scopus, Web of Science and Cochrane Library were searched to detect relevant publications up to 1 April 2020, using relevant keywords. To pool data, a fixed- or random-effects model was used depending on the heterogeneity between studies. Furthermore, publication bias test and sensitivity analysis were also done. RESULTS: In total, 20 retrospective studies with 3,428 COVID-19 infected patients (severe cases = 1,455 and mild cases = 1,973), were included in this meta-analysis. Higher serum levels of Aspartate aminotransferase (weighted mean difference = 8.84 U/L, 95% CI = 5.97 to 11.71, P<0.001), Alanine aminotransferase (weighted mean difference = 7.35 U/L, 95% CI = 4.77 to 9.93, P<0.001), total Bilirubin (weighted mean difference = 2.30 mmol/L, 95% CI = 1.24 to 3.36, P<0.001) and lower serum levels of Albumin (weighted mean difference = -4.24 g/L, 95% CI = -6.20 to -2.28, P<0.001), were associated with a significant increase in the severity of COVID-19 infection. CONCLUSIONS: The incidence of liver injury, as assessed by serum analysis (AST, ALT, total Bilirubin and Albumin levels), seems to be higher in patients with severe COVID-19 infection.","Hepatol Res","Parohan, Mohammad","Yaghoubi, Sajad","Seraj, Asal","32386449"],"abstract":["AIM: The Coronavirus disease 2019 (COVID-19) outbreak is a major threat to human beings. Lung injury has been reported as the major outcome of COVID-19 infection. However, liver damage has also been considered to occur in severe cases. Current meta-analysis of retrospective studies was done to summarize available findings on the association between liver injury and severity of COVID-19 infection. METHODS: Online databases including PubMed, Scopus, Web of Science and Cochrane Library were searched to detect relevant publications up to 1 April 2020, using relevant keywords. To pool data, a fixed- or random-effects model was used depending on the heterogeneity between studies. Furthermore, publication bias test and sensitivity analysis were also done. RESULTS: In total, 20 retrospective studies with 3,428 COVID-19 infected patients (severe cases = 1,455 and mild cases = 1,973), were included in this meta-analysis. Higher serum levels of Aspartate aminotransferase (weighted mean difference = 8.84 U/L, 95% CI = 5.97 to 11.71, P<0.001), Alanine aminotransferase (weighted mean difference = 7.35 U/L, 95% CI = 4.77 to 9.93, P<0.001), total Bilirubin (weighted mean difference = 2.30 mmol/L, 95% CI = 1.24 to 3.36, P<0.001) and lower serum levels of Albumin (weighted mean difference = -4.24 g/L, 95% CI = -6.20 to -2.28, P<0.001), were associated with a significant increase in the severity of COVID-19 infection. CONCLUSIONS: The incidence of liver injury, as assessed by serum analysis (AST, ALT, total Bilirubin and Albumin levels), seems to be higher in patients with severe COVID-19 infection."],"journal":"Hepatol Res","authors":["Parohan, Mohammad","Yaghoubi, Sajad","Seraj, Asal"],"date":"2020-05-10T11:00:00Z","year":2020,"_id":"32386449","source":"PubMed","week":"202019|May 04 - May 10","doi":"10.1111/hepr.13510","keywords":["covid-19","meta-analysis","sars-cov-2","liver","novel coronavirus"],"topics":["Diagnosis","Treatment"],"weight":1,"_version_":1666340102067978240,"score":222.72055}]}